Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture
- PMID: 3791211
Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture
Abstract
Shionogi carcinoma 115 (SC115) had been accepted for 20 years as an androgen-dependent mouse mammary tumor, the growth of which is stimulated only by androgen. However, we very recently found that the growth of SC115 tumors in vivo is stimulated not only by physiological doses of androgen but also by pharmacological doses of estrogen through the estrogen receptor system. In the present study, the growth-stimulative effect of estrogen on an androgen-dependent cloned cell line (SC-3) derived from SC115 cells, which showed androgen- and estrogen-dependent growth in vivo, was examined in vitro. In serum-supplemented medium (Eagle's minimum essential medium containing 2% steroid-free fetal calf serum), testosterone or 5 alpha-dihydrotestosterone (10(-9)-10(-6) M) significantly stimulated the growth of SC-3 cells (3.2-fold increase in cell number at day 10 in culture containing 10(-8) M androgens) and changed the shape of SC-3 cells from epithelial to spindle (fibroblast-like), whereas 17 beta-estradiol (10(-12)-10(-6) M) even in high concentrations had no such effects on SC-3 cells. Contrary to the effect of 17 beta-estradiol in vivo, 17 beta-estradiol as well as cyproterone acetate (10(-8)-10(-6) M) inhibited the growth-stimulative effect of testosterone (10(-8) M) on SC-3 cells in a dose-dependent manner in the serum-supplemented medium. The anti-androgen and 17 beta-estradiol also showed comparable competitive effects on [3H]testosterone binding to androgen receptor in SC-3 cells. In serum-free medium [Ham's F-12:Eagle's minimum essential medium (1:1, v/v) containing 0.2% bovine serum albumin], testosterone [10(-8) M] also markedly stimulated the growth of spindle-shaped SC-3 cells, and epidermal growth factor (1 ng/ml) enhanced the growth-stimulative effect of testosterone, whereas 17 beta-estradiol (10(-8)-10(-6) M) in the absence or presence of epidermal growth factor had no growth-stimulative effect on SC-3 cells. We conclude that the growth of SC115 cells is stimulated by either physiological doses of androgen or pharmacological doses of estrogen in vivo but only by androgen in cell culture.
Similar articles
-
Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.Cancer Res. 1987 Aug 15;47(16):4329-34. Cancer Res. 1987. PMID: 3607765
-
Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.Cancer Res. 1987 Dec 15;47(24 Pt 1):6560-4. Cancer Res. 1987. PMID: 3677094
-
Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice.Cancer Res. 1985 Nov;45(11 Pt 2):5746-50. Cancer Res. 1985. PMID: 4053046
-
[Hormone dependence in breast and prostate tumor cell lines].Rev Esp Fisiol. 1990 Mar;46(1):83-7. Rev Esp Fisiol. 1990. PMID: 2204094 Review. Spanish.
-
Sex steroids and growth factors in mammary cancer.Acta Endocrinol (Copenh). 1991;125 Suppl 1:38-41. Acta Endocrinol (Copenh). 1991. PMID: 1801502 Review.
Cited by
-
Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115).Jpn J Cancer Res. 1993 Jun;84(6):656-63. doi: 10.1111/j.1349-7006.1993.tb02026.x. Jpn J Cancer Res. 1993. PMID: 8340254 Free PMC article.
-
Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.In Vitro Cell Dev Biol. 1992 Apr;28A(4):245-54. doi: 10.1007/BF02634240. In Vitro Cell Dev Biol. 1992. PMID: 1374755
-
Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).Jpn J Cancer Res. 1992 Sep;83(9):995-1001. doi: 10.1111/j.1349-7006.1992.tb02013.x. Jpn J Cancer Res. 1992. PMID: 1429212 Free PMC article.
-
Facilitation of autonomous phenotype acquisition in androgen-dependent Shionogi carcinoma 115 cells by transfection of androgen-induced growth factor expression vector.Jpn J Cancer Res. 1994 Nov;85(11):1117-23. doi: 10.1111/j.1349-7006.1994.tb02916.x. Jpn J Cancer Res. 1994. PMID: 7829396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous